Alzheimer's disease (AD) constitutes a devastating neurodegenerative disorder, manifested by amyloid‐β aggregation, phosphorylated tau accumulation, and progressive cognitive deterioration. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.